Glucocorticoids and other immunosuppressive drugs, such as cyclosporin
e A, are increasingly used today. One of the most common clinical situ
ations in which they are prescribed is for immunosuppression after org
an transplantation These drugs have diverse effects on the skeleton, h
owever, and one of the most common sequelae of organ transplantation i
s osteoporosis and fractures. Patients treated with immunosuppressive
drugs should be carefully evaluated for osteoporosis, preferably prior
to or at the time of initiation of immunosuppressive therapy. They sh
ould be followed carefully with sequential bone-density measurements a
nd biochemical indices of bone turnover Measures to prevent bone loss
should be initiated early in the course of immunosuppressive therapy.